lily glp-1 Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Lilly reports positive phase 3

Future research should focus on improving the efficiency of genetic engineering, overcoming the challenges posed by anaerobic characteristics and spore germination, minimizing the metabolic burden on host bacteria, reducing immunogenicity, and enhancing colonization efficiency

While they are highly effective, they are powerful medications that should only be used under the guidance of a healthcare professional

Promotion of Satiety By acting on the hypothalamus and other areas of the brain, GLP-1 reduces appetite and promotes feelings of fullness

Glucagon-Like Peptide-1 Activates Endothelial Nitric Oxide Synthase in Human Umbilical Vein Endothelial Cells